International Medicinal Product Information Documents: A Quantitative Content Analysis of Instructions for Preventing, Mitigating, and Monitoring Adverse Drug Reactions
-
By
-
March 21, 2026
-
1
The study analyzed 627 signals of adverse drug reactions, focusing on the completeness of instructions in product information documents.
-
2
Instructions for prevention and mitigation were complete in only 30% of documents, while monitoring instructions were complete in 22%.
-
3
Product information documents from the European Union and Canada provided the most comprehensive information on adverse drug reactions.
-
4
Disagreement analysis revealed international differences in documenting adverse reactions, suggesting a need for global collaboration.
-
5
The research highlights the inadequacy of current guidelines and the necessity for updated international studies on product information documents.
